Lobbying client

ADAPT PHARMA

Small business focused on developing treatments for patients with medical conditions.

The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 2 of its records are shown together here.

Filings
37
Filed by
2
Reported in-house
—
Reported by firms
$895,000

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2016 to 2022

Filings

37 filings, newest first.
Filing Filed by Amount
2nd Quarter - Termination (No Activity)
2nd Quarter 2022
FORBES-TATE — reported
1st Quarter - Report (No Activity)
1st Quarter 2022
FORBES-TATE — reported
4th Quarter - Report (No Activity)
4th Quarter 2021
FORBES-TATE — reported
3rd Quarter - Report (No Activity)
3rd Quarter 2021
FORBES-TATE — reported
2nd Quarter - Report (No Activity)
2nd Quarter 2021
FORBES-TATE — reported
1st Quarter - Report (No Activity)
1st Quarter 2021
FORBES-TATE — reported
4th Quarter - Report (No Activity)
4th Quarter 2020
FORBES-TATE — reported
3rd Quarter - Report (No Activity)
3rd Quarter 2020
FORBES-TATE — reported
2nd Quarter - Report (No Activity)
2nd Quarter 2020
FORBES-TATE — reported
1st Quarter - Report (No Activity)
1st Quarter 2020
FORBES-TATE — reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
FORBES-TATE 24 $815,000
DENTONS US LLP 10 $80,000

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Health Issues HCR 15

Bills named in its filings

Bill numbers found in the filers' descriptions, most often named first.

BillCongressTimes named
S. 524 114th 5
H.R. 6470 115th 1
S. 3158 115th 1
H.R. 6157 115th 1

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.